I. Oncel Et Al. , "Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study," PEDIATRIC NEUROLOGY , vol.110, pp.59-63, 2020
Oncel, I. Et Al. 2020. Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study. PEDIATRIC NEUROLOGY , vol.110 , 59-63.
Oncel, I., SANCAR, M., KONUŞKAN, B., Arioz, F., TEZCAN, S., ARMAN KANDIRMAZ, E., ... PARLAK, Ş.(2020). Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study. PEDIATRIC NEUROLOGY , vol.110, 59-63.
Oncel, Ibrahim Et Al. "Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study," PEDIATRIC NEUROLOGY , vol.110, 59-63, 2020
Oncel, Ibrahim Et Al. "Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study." PEDIATRIC NEUROLOGY , vol.110, pp.59-63, 2020
Oncel, I. Et Al. (2020) . "Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study." PEDIATRIC NEUROLOGY , vol.110, pp.59-63.
@article{article, author={Ibrahim Oncel Et Al. }, title={Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study}, journal={PEDIATRIC NEUROLOGY}, year=2020, pages={59-63} }